BOISE, ID, UNITED STATES, January 20, 2026 /EINPresswire.com/ — Sekady, a leading provider of construction lending technology solutions, today announced a strategic ...

SAN CARLOS, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is ...

Designed to empower users to understand the causes of their headaches, the app now includes a suite of tools to log symptoms, analyze, track treatment efficacy We created this app to address a very ...

Manchester City are close to agreeing terms with Bournemouth to sign Antoine Semenyo for £65m - but Andoni Iraola insists the forward has "definitely not" played his last game for the Cherries. City's ...

TORONTO and HOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

draw.io Desktop is a free, offline diagramming tool for creating flowcharts, org charts, network diagrams, and more. It supports multiple formats and integrates with cloud storage for syncing. draw.io ...

(RTTNews) - IO Biotech (IOBT), a clinical-stage biopharmaceutical company focused on cancer vaccines, Monday reported positive phase 3 results for Cylembio, in combination with Merck & Co Inc.'s (MRK) ...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...